122 related articles for article (PubMed ID: 37536482)
1. A PSD-95 peptidomimetic mitigates neurological deficits in a mouse model of Angelman syndrome.
Lau KA; Yang X; Rioult-Pedotti MS; Tang S; Appleman M; Zhang J; Tian Y; Marino C; Yao M; Jiang Q; Tsuda AC; Huang YA; Cao C; Marshall J
Prog Neurobiol; 2023 Nov; 230():102513. PubMed ID: 37536482
[TBL] [Abstract][Full Text] [Related]
2. Impairment of TrkB-PSD-95 signaling in Angelman syndrome.
Cao C; Rioult-Pedotti MS; Migani P; Yu CJ; Tiwari R; Parang K; Spaller MR; Goebel DJ; Marshall J
PLoS Biol; 2013; 11(2):e1001478. PubMed ID: 23424281
[TBL] [Abstract][Full Text] [Related]
3. BDNF mechanisms in late LTP formation: A synthesis and breakdown.
Panja D; Bramham CR
Neuropharmacology; 2014 Jan; 76 Pt C():664-76. PubMed ID: 23831365
[TBL] [Abstract][Full Text] [Related]
4. UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticity.
Sun J; Liu Y; Jia Y; Hao X; Lin WJ; Tran J; Lynch G; Baudry M; Bi X
Elife; 2018 Jul; 7():. PubMed ID: 30020076
[TBL] [Abstract][Full Text] [Related]
5. BDNF-induced local protein synthesis and synaptic plasticity.
Leal G; Comprido D; Duarte CB
Neuropharmacology; 2014 Jan; 76 Pt C():639-56. PubMed ID: 23602987
[TBL] [Abstract][Full Text] [Related]
6. Recovery of Angelman syndrome rat deficits with UBE3A protein supplementation.
Dodge A; Morrill NK; Weeber EJ; Nash KR
Mol Cell Neurosci; 2022 May; 120():103724. PubMed ID: 35367589
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design of peptidomimetic inhibitors of PSD-95 with improved affinity for the PDZ3 domain.
Naik MT; Naik N; Hu T; Wang SH; Marshall J
FEBS Lett; 2024 Jan; 598(2):233-241. PubMed ID: 37904289
[TBL] [Abstract][Full Text] [Related]
8. Ampakines promote spine actin polymerization, long-term potentiation, and learning in a mouse model of Angelman syndrome.
Baudry M; Kramar E; Xu X; Zadran H; Moreno S; Lynch G; Gall C; Bi X
Neurobiol Dis; 2012 Aug; 47(2):210-5. PubMed ID: 22525571
[TBL] [Abstract][Full Text] [Related]
9. Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.
Sun J; Liu Y; Moreno S; Baudry M; Bi X
J Neurosci; 2015 Mar; 35(11):4706-18. PubMed ID: 25788687
[TBL] [Abstract][Full Text] [Related]
10. Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome.
Hethorn WR; Ciarlone SL; Filonova I; Rogers JT; Aguirre D; Ramirez RA; Grieco JC; Peters MM; Gulick D; Anderson AE; L Banko J; Lussier AL; Weeber EJ
Eur J Neurosci; 2015 May; 41(10):1372-80. PubMed ID: 25864922
[TBL] [Abstract][Full Text] [Related]
11. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic interference with BDNF/TrkB-signaling impair LTP selectively at mossy fiber synapses in the CA3 region of mouse hippocampus.
Schildt S; Endres T; Lessmann V; Edelmann E
Neuropharmacology; 2013 Aug; 71():247-54. PubMed ID: 23587649
[TBL] [Abstract][Full Text] [Related]
13. α1-Na/K-ATPase inhibition rescues aberrant dendritic calcium dynamics and memory deficits in the hippocampus of an Angelman syndrome mouse model.
Rayi PR; Koyavski L; Chakraborty D; Bagrov A; Kaphzan H
Prog Neurobiol; 2019 Nov; 182():101676. PubMed ID: 31401139
[TBL] [Abstract][Full Text] [Related]
14. Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model.
Huie EZ; Yang X; Rioult-Pedotti MS; Naik M; Huang YA; Silverman JL; Marshall J
bioRxiv; 2024 Jun; ():. PubMed ID: 38895218
[TBL] [Abstract][Full Text] [Related]
15. Repetitive transcranial magnetic stimulation (rTMS) influences spatial cognition and modulates hippocampal structural synaptic plasticity in aging mice.
Ma J; Zhang Z; Kang L; Geng D; Wang Y; Wang M; Cui H
Exp Gerontol; 2014 Oct; 58():256-68. PubMed ID: 25172625
[TBL] [Abstract][Full Text] [Related]
16. Environmental enrichment improves long-term memory impairment and aberrant synaptic plasticity by BDNF/TrkB signaling in nerve-injured mice.
Wang XM; Pan W; Xu N; Zhou ZQ; Zhang GF; Shen JC
Neurosci Lett; 2019 Feb; 694():93-98. PubMed ID: 30496785
[TBL] [Abstract][Full Text] [Related]
17. A role for BDNF- and NMDAR-induced lysosomal recruitment of mTORC1 in the regulation of neuronal mTORC1 activity.
Khamsing D; Lebrun S; Fanget I; Larochette N; Tourain C; de Sars V; Brunstein M; Oheim M; Carrel D; Darchen F; Desnos C
Mol Brain; 2021 Jul; 14(1):112. PubMed ID: 34247625
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A
Moreira-de-Sá A; Gonçalves FQ; Lopes JP; Silva HB; Tomé ÂR; Cunha RA; Canas PM
Neurobiol Dis; 2020 Dec; 146():105137. PubMed ID: 33049319
[TBL] [Abstract][Full Text] [Related]
19. Rescue of Learning and Memory Deficits in the Human Nonsyndromic Intellectual Disability Cereblon Knock-Out Mouse Model by Targeting the AMP-Activated Protein Kinase-mTORC1 Translational Pathway.
Bavley CC; Rice RC; Fischer DK; Fakira AK; Byrne M; Kosovsky M; Rizzo BK; Del Prete D; Alaedini A; Morón JA; Higgins JJ; D'Adamio L; Rajadhyaksha AM
J Neurosci; 2018 Mar; 38(11):2780-2795. PubMed ID: 29459374
[TBL] [Abstract][Full Text] [Related]
20. [Electroacupuncture improves learning and memory impairment and enhances hippocampal synaptic plasticity through BDNF/TRKB/CREB signaling pathway in cerebral ischemia-reperfusion injury rats].
Yuan J; Gao J; Su KQ; Feng XD
Zhen Ci Yan Jiu; 2023 Sep; 48(9):843-51. PubMed ID: 37730254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
